Company: VERA
Filing Date: 2025-12-10
Form Type: 424B5
Source: 0001193125-25-314244
Chunk: 13

Company: Vera Therapeutics, Inc.
Filing Date: 2025-12-10
Form: 424B5
Chunk 13
---
 |     | 1,438,856 shares of our Class A common stock reserved for issuance under our ESPP as of September 30, 2025; |

| • |     | Any future increases in the number of shares of our Class A common stock reserved for issuance under the ESPP; |

| • |     | 832,555 shares of our Class A common stock reserved for issuance under our Inducement Plan as of September 30, 2025; 
 and                                                                                                                  |

| • |     | Any future increases in the number of shares of our Class A common stock reserved for issuance under the Inducement 
 Plan.                                                                                                               |

To the extent that any outstanding options are exercised, outstanding restricted stock units vest or settle, or new options or restricted stock units are issued under our stock-based compensation plans, or we issue additional shares of Class A common stock in the future, there will be further dilution to investors participating in this offering. S-11

Material U.S. federal income tax consequences to Non-U.S.Holders The following discussion is a summary of the material U.S. federal income tax consequences to Non-U.S.Holders (as defined below) of the purchase, ownership and disposition of our Class A common stock issued pursuant to this offering, but does not purport to be a complete analysis of all potential tax effects. The effects of other U.S. federal tax laws, such as estate and gift tax laws, and any applicable state, local or non-U.S.tax laws are not discussed. This discussion is based on the U.S. Internal Revenue Code of 1986, as amended (the “Code”), Treasury Regulations promulgated thereunder, judicial decisions, and published rulings and administrative pronouncements of the U.S. Internal Revenue Service (the “IRS”), in each case in effect as of the date hereof. These authorities may change or be subject to differing interpretations. Any such change or differing interpretation may be applied retroactively in a manner that could adversely affect a Non-U.S.Holder. We have not sought and will not seek any rulings from the IRS regarding the matters discussed below. There can be no assurance the IRS or a court will not take a contrary position to that discussed below regarding the tax consequences of the purchase, ownership and disposition of our Class A common stock. This discussion is limited to Non-U.S.Holders that hold our Class A common stock as a “capital asset” within the meaning of Section 1221 of the Code (generally, property held for